Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine

Saturday, February 13th, 2010

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced that its ToleroMune(R) ragweed allergy T-cell vaccine achieved positive results in a recently completed phase II clinical trial. Ragweed allergy is particularly common in America, where it affects approximately 25% of the population. Circassia's latest clinical results follow ...

Brain Waves Show Patterns For Deciding Which Faces We Prefer

Thursday, February 11th, 2010

Current Article Ratings: Patient / Public: Health Professional: Article Opinions: Faces play a very important role in our social life. We make complex social decisions based on facial appearance. Extensive research has been made to identify a set of facial features which ...

Gene Variant For Biological Ageing In Humans Discovered

Monday, February 8th, 2010

Scientists from the UK and The Netherlands have identified for the first time a variant of a gene that is linked to biological ageing in humans and suggest the discovery will help us better understand cancer and diseases of ageing. The findings of the study by researchers ...

Everyone Wins At The Olympic Winter Games With Healthy Travel Preparations

Friday, February 5th, 2010

Sports fans attending the 2010 Olympic Winter Games and the Paralympics Games in Vancouver, Canada, in February can be winners if they make plans now to help stay healthy during their trip. The Centers for Disease Control and Prevention offers some simple tips to help travelers share gold ...